DK1062333T3 - Chondrosarcoma-associeret gener - Google Patents

Chondrosarcoma-associeret gener

Info

Publication number
DK1062333T3
DK1062333T3 DK99909962T DK99909962T DK1062333T3 DK 1062333 T3 DK1062333 T3 DK 1062333T3 DK 99909962 T DK99909962 T DK 99909962T DK 99909962 T DK99909962 T DK 99909962T DK 1062333 T3 DK1062333 T3 DK 1062333T3
Authority
DK
Denmark
Prior art keywords
chondrosarcoma
associated genes
gene
nucleic acid
methods
Prior art date
Application number
DK99909962T
Other languages
Danish (da)
English (en)
Inventor
Richard M Terek
Original Assignee
Rhode Island Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhode Island Hospital filed Critical Rhode Island Hospital
Application granted granted Critical
Publication of DK1062333T3 publication Critical patent/DK1062333T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57557—Immunoassay; Biospecific binding assay; Materials therefor for cancer of other specific parts of the body, e.g. brain
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57595—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving intracellular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
DK99909962T 1998-03-13 1999-03-12 Chondrosarcoma-associeret gener DK1062333T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/042,225 US6207812B1 (en) 1998-03-13 1998-03-13 Chondrosarcoma associated genes
PCT/US1999/005348 WO1999046382A1 (en) 1998-03-13 1999-03-12 Chondrosarcoma associated genes

Publications (1)

Publication Number Publication Date
DK1062333T3 true DK1062333T3 (da) 2009-01-26

Family

ID=21920744

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99909962T DK1062333T3 (da) 1998-03-13 1999-03-12 Chondrosarcoma-associeret gener

Country Status (11)

Country Link
US (2) US6207812B1 (https=)
EP (1) EP1062333B1 (https=)
JP (1) JP2002506617A (https=)
AT (1) ATE408686T1 (https=)
AU (1) AU762987B2 (https=)
CA (1) CA2323076A1 (https=)
DE (1) DE69939583D1 (https=)
DK (1) DK1062333T3 (https=)
ES (1) ES2317690T3 (https=)
PT (1) PT1062333E (https=)
WO (1) WO1999046382A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2010003371A (es) 2007-09-28 2010-05-05 Intrexon Corp Constructos interruptores genicos terapeuticos y biorreactores para la expresion de moleculas bioterapeuticas y usos de los mismos.
KR102181548B1 (ko) * 2019-02-20 2020-11-20 한국외국어대학교 연구산학협력단 염증성 질환 또는 자가면역성 질환의 예방 또는 치료 활성을 갖는 펩타이드 및 이의 용도

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873191A (en) 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
US5175385A (en) 1987-09-03 1992-12-29 Ohio University/Edison Animal Biotechnolgy Center Virus-resistant transgenic mice
US5175384A (en) 1988-12-05 1992-12-29 Genpharm International Transgenic mice depleted in mature t-cells and methods for making transgenic mice
US5350835A (en) * 1991-11-05 1994-09-27 Board Of Regents, University Of Texas Cellular nucleic acid binding protein and uses thereof in regulating gene expression and in the treatment of aids
US5744343A (en) * 1994-01-04 1998-04-28 Mitotix, Inc. Ubiquitin conjugating enzymes
US5612455A (en) * 1994-07-05 1997-03-18 Tularik, Inc. Nuclear factors and binding assay

Also Published As

Publication number Publication date
US6207812B1 (en) 2001-03-27
JP2002506617A (ja) 2002-03-05
AU762987B2 (en) 2003-07-10
DE69939583D1 (de) 2008-10-30
WO1999046382A1 (en) 1999-09-16
US20010016649A1 (en) 2001-08-23
AU2904099A (en) 1999-09-27
US7211646B2 (en) 2007-05-01
ES2317690T3 (es) 2009-04-16
PT1062333E (pt) 2008-12-24
CA2323076A1 (en) 1999-09-16
EP1062333B1 (en) 2008-09-17
EP1062333A1 (en) 2000-12-27
ATE408686T1 (de) 2008-10-15

Similar Documents

Publication Publication Date Title
IT1314250B1 (it) Proteine (iip) che interagiscono con il recettore igf-1 geni che lecodificano e loro impiego.
DE60030145D1 (de) Nachweisverfahren für kurze sequenzvarianten
EP1131333A4 (en) INSULATED NUCLEIC ACID MOLECULES ENCODING INDUCIBLE FACTORS DERIVED FROM T-CELL (TIF), ENCODED PROTEINS AND USE THEREOF
DE69833784D1 (de) Polypeptide mit aminopeptidaseaktivität und für diese kodierende nukleinsäuren
DE69333718D1 (de) Gen, das für eine Fisch-Transglutaminase kodiert
DE60042556D1 (de) Für polyepitop-polypeptide kodierende nukleinsäuren
DE69634412D1 (de) Regulierte gene und ihre verwendungen
NO910982D0 (no) Uratoksydase-aktivt protein, rekombinant gen som koder for det, ekspresjonsvektor, mikroorganismer og transformerteceller.
AR015687A2 (es) Gen aislado que codifica acil transferasa
DE60109430D1 (de) An entzündlichen darmerkrankungen beteiligte gene und deren verwendung
DE69532033D1 (de) Für ein fibroblasten-aktivierungsprotein kodierende nukleinsäure und verwendungen dafür
DE69634918D1 (de) Polynukleotide und polypeptide aus pathogenen mycobakterien und deren verwendung als diagnostika, impfstoffe und als ziel der chemotherapie
DK1082423T3 (da) Cyclin E2-gener og -proteiner
ATE202570T1 (de) Gene, die für macif proteine kodieren, expressionsvektoren mit diesem genen, und transformantenzellen mit diesem proteinen
DK0877758T3 (da) Oprenset SR-p70-protein
DK1062333T3 (da) Chondrosarcoma-associeret gener
DK0643719T3 (da) Nukleinsyresekvenser, som koder for eller er komplementære til nukleinsyresekvenser, som koder for interleukin 9-receptor
NZ518458A (en) Isolate DNA polymerase lambda and uses thereof
NO902087L (no) Alfa-amylase-pullulanase-enzym og dna-sekvens som koder for dette, rekombinant dna-molekyl og en rekombinant klon som uttrykker enzymet.
EP0970192A4 (en) NUCLEIC ACID CODING THE ALGU PROTEIN OF M. TUBERCULOSIS.
PE20399A1 (es) Muteina ob
ATE262034T1 (de) Xylanasen, für diese kodierende gene und anwendungen derselben
DE69832447D1 (de) Gen kodierend für Afadin-1
ATE348109T1 (de) Das gen prv-1 und dessen verwendung
DE60040668D1 (de) Antibakterielles protein chlamysin-b, dafür kodierendes gen und ein expresionssystem dafür